Lb Pharmaceuticals (LBRX) Equity Average (2024 - 2026)
Lb Pharmaceuticals' quarterly Equity Average came in at $340.0 million in Q1 2026, up 450.71% year-on-year from $61.7 million in Q1 2025, and up 11.2% quarter-over-quarter from $305.8 million in Q4 2025.
Lb Pharmaceuticals has reported Equity Average for 3 years, with the latest figure at $340.0 million in Q1 2026.
- For the quarter ending Q1 2026, Equity Average rose 450.71% year-over-year to $340.0 million; the trailing twelve-month figure through Mar 2026 stood at $340.0 million (up 450.71% YoY), and the FY2025 full-year result was $103.4 million, changed N/A from the prior year.
- Equity Average for Q1 2026 stood at $340.0 million, up from $305.8 million in the prior quarter.
- The five-year high for Equity Average was $340.0 million in Q1 2026, with the low at -$96.9 million in Q1 2025.
- Average Equity Average over 3 years is $112.3 million, with a median of $105.4 million recorded in 2025.
- Year-over-year, Equity Average jumped 428.77% in 2025 and soared 450.71% in 2026.
- Tracing LBRX's Equity Average over 3 years: stood at -$93.0 million in 2024, then jumped by 428.77% to $305.8 million in 2025, then increased by 11.2% to $340.0 million in 2026.
- The last three Equity Average figures came in at $340.0 million (Q1 2026), $305.8 million (Q4 2025), and $105.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 3.76 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 21.35 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 19.01 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 31.34 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 932.28 Mn |
| 10 | Lb Pharmaceuticals | 789.92 Mn | 789.92 Mn | - | 340.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 340.00 Mn |
| Dec 31, 2025 | 305.77 Mn |
| Sep 30, 2025 | 105.44 Mn |
| Mar 31, 2025 | -96.95 Mn |
| Dec 31, 2024 | -93.00 Mn |